Human Genome Sciences, Isis Pharmaceuticals deal

The companies formed a collaboration to create antisense drugs using ISIP’s antisense drug discovery and HGSI’s library of gene targets.

The companies plan to develop partnerships with pharmaceutical companies to fund joint R&D programs to create antisense drugs aimed at novel gene targets. HGSI (Rockville, Md.) and ISIP (San Diego) will manage and share equally in the proceeds from any third-party collaboration. ...